Suppr超能文献

商品名或批准名。第四部分。解决方案。我们应该如何开处方?

Trade names or approved names. Part IV. The solution. How should we prescribe?

作者信息

Vere D W

出版信息

Postgrad Med J. 1974 Feb;50(580):122-4. doi: 10.1136/pgmj.50.580.122.

Abstract

Approved names, though often bulky, are preferable on balance to brand names because they identify drugs precisely by compound, often revealing derivation and class of action as well. Brand names at present have the advantage of identifying a preparation. This affirms bio-availability, if that is known, and safeguards the consumer's legal position. But both advantages are against drug defects. It should therefore be hoped that they will become obsolete through pharmaceutical progress, and so do not constitute a lasting reason to confound prescribing accuracy with financial expediency.

摘要

通用名虽然通常冗长,但总体上比商品名更可取,因为它们能通过化合物精确识别药物,还常常揭示其来源和作用类别。目前商品名具有识别制剂的优势。如果已知生物利用度,这能确认其生物利用度,并保障消费者的合法权益。但这两个优势都无法对抗药物缺陷。因此,希望随着制药技术的进步,商品名会过时,所以不能成为将处方准确性与财务权宜之计混淆的持久理由。

相似文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验